Gene · 10219
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Zeb2 regulates differentiation of long-lived effector of invariant natural killer T cells. | Commun Biol | 2023 | 37903859 | PubTator, text mining | PubMed |
| Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration. | Front Aging | 2023 | 37900152 | PubTator, text mining | PubMed |
| CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response. | J Exp Clin Cancer Res | 2023 | 37898752 | PubTator, text mining | PubMed |
| A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development. | Nat Commun | 2023 | 37898600 | PubTator, text mining | PubMed |
| Molecular Subtype Classification of Postmenopausal Osteoporosis and Immune Infiltration Microenvironment Based on Bioinformatics Analysis of Osteoclast-Regulatory Genes. | Biomedicines | 2023 | 37893075 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming. | Nat Commun | 2023 | 37891230 | PubTator, text mining | PubMed |
| An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer. | Res Sq | 2023 | 37886475 | PubTator, text mining | PubMed |
| MAIT cells altered phenotype and cytotoxicity in lupus patients are linked to renal disease severity and outcome. | Front Immunol | 2023 | 37885889 | PubTator, text mining | PubMed |
| The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment. | Front Immunol | 2023 | 37881432 | PubTator, text mining | PubMed |
| Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy. | J Hematol Oncol | 2023 | 37880715 | PubTator, text mining | PubMed |
| Developing synthetic tools to decipher the tumor-immune interactome. | Proc Natl Acad Sci U S A | 2023 | 37871202 | PubTator, text mining | PubMed |
| Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells. | Front Immunol | 2023 | 37868997 | PubTator, text mining | PubMed |
| Regulatory T cells in skin regeneration and wound healing. | Mil Med Res | 2023 | 37867188 | PubTator, text mining | PubMed |
| An interpretable machine learning pipeline based on transcriptomics predicts phenotypes of lupus patients. | iScience | 2023 | 37860757 | PubTator, text mining | PubMed |
| IL-27 produced during acute malaria infection regulates Plasmodium-specific memory CD4+ T cells. | EMBO Mol Med | 2023 | 37855243 | PubTator, text mining | PubMed |
| Trimodal single-cell profiling reveals a novel pediatric CD8αα+ T cell subset and broad age-related molecular reprogramming across the T cell compartment. | Nat Immunol | 2023 | 37845489 | PubTator, text mining | PubMed |
| C-reactive protein impairs immune response of CD8+ T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma. | J Immunother Cancer | 2023 | 37844994 | PubTator, text mining | PubMed |
| Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients. | EBioMedicine | 2023 | 37844534 | PubTator, text mining | PubMed |
| Regulatory T cells and cardiovascular diseases. | Chin Med J (Engl) | 2023 | 37840195 | PubTator, text mining | PubMed |
| Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis. | Cancers (Basel) | 2023 | 37835465 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10219/papers?page=16